trial · primary record
sonrotoclax
Relapsed Acute Myeloid Leukemia
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2031-09 |
| Primary endpoint | Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT07770698 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:15.116Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07770698
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.